doc. MUDr. Andrea Janíková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 3514, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 176
2023
-
Konsolidační léčba brentuximab vedotinem u pacientů s relabujícím/refrakterním klasickým Hodgkinovým lymfomem po provedení autologní transplantace hematopoetických kmenových buněk v České republice
Onkologie, year: 2023, volume: 17, edition: 4, DOI
-
Volná cirkulující DNA a její potenciál v diagnostice a léčbě maligních lymfomů
Klinicka Onkologie, year: 2023, volume: 36, edition: 4, DOI
2022
-
Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
FRONTIERS IN CARDIOVASCULAR MEDICINE, year: 2022, volume: 9, edition: April 2022, DOI
-
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)
Annals of hematology, year: 2022, volume: 101, edition: 4, DOI
-
Comparison of DNA and RNA-based approaches for the genetic characterization and stratification of patients with diffuse large B-cell lymphoma
Year: 2022, type: Conference abstract
-
Consolidation Therapy with Brentuximab Vedotin After Autologous Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Czech Republic.
Year: 2022, type: Conference abstract
-
Cvičební programy pro hematoonkologické pacienty
Year: 2022, type:
-
Integrated NGS testing and cfDNA analysis as an approach for aggregate tumor characterization and monitoring in a patient with aggressive lymphoma invading the central neural system.
Year: 2022, type: Conference abstract
-
Korelácia chromozomálnych aberácií zistených metodou aCGH s expresiou vybraných génov u pacientov s difúznym vel´kobunkovým B-lymfómom.
Year: 2022, type: Conference abstract
-
Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world
European Journal of Haematology, year: 2022, volume: 109, edition: 2, DOI